• Medical - Distribution
  • Healthcare
McKesson Corporation logo
McKesson Corporation
MCK · US · NYSE
600.16
USD
+4.43
(0.74%)
Company Overview

6555 STATE HIGHWAY 161,IRVING TX 75039,972-446-4800

CEO

Mr. Brian S. Tyler Ph.D.

Employess

45000

Sector

Healthcare

Industry

Medical - Distribution

Website

https://www.mckesson.com

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Next Earnings Date

Oct. 30, 2024

Ex Dividends date

Jul. 01, 2024

Dividend Date

June 3, 2024

YTD Performance

26.77%

Fiscal Year End

03-31

IPO Date

1994-11-10

Growth Rates
(avg. rate of change) 10 years 5 years 3 years 1 year
Sales/Revenue 8.42% 7.59% 9.05% 11.65%
EPS 15.13% 165.77% 41.52% -10.66%
Equity -2.10% -4.46% -354.45% -6.14%
Cash 0.90% 8.99% -9.95% -1.99%
Return On Capital (ROIC) 29.30% 46.23% 62.50% 86.41%
Debt
year (millions) 2024 2023 2022 2021 2020
Short Term Debt 345 1,270 1,100 1,130 1,410
Long Term Debt 5,420 6,030 6,450 8,270 8,000
LT Finance Leases 1,630 1,700 1,660 2,260 2,010
Shares Outstanding 133 141 152 161 181
Market Cap 71,500 50,200 46,600 31,300 24,500
Price
Business Segments (Beta)
Geographical Segments (Beta)
News
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know
2 months

In the latest trading session, McKesson (MCK) closed at $600.16, marking a +0.74% move from the previous day.

zacks.com
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
2 months

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

zacks.com
McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know
2 months

McKesson (MCK) closed at $585.74 in the latest trading session, marking a +0.47% move from the prior day.

zacks.com
McKesson (MCK) Gains 26% Year to Date: What's Backing the Rally?
2 months

McKesson's (MCK) shares have risen 1.5% year to date on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top line.

zacks.com
Here's Why McKesson (MCK) is a Strong Value Stock
2 months

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com
3 Reasons Why You Should Hold McKesson (MCK) Stock for Now
2 months

McKesson's (MCK) robust Biologics business raises optimism about the stock.

zacks.com
McKesson (MCK) Declines More Than Market: Some Information for Investors
2 months

In the latest trading session, McKesson (MCK) closed at $575.23, marking a -1.98% move from the previous day.

zacks.com
Here's Why McKesson (MCK) is a Strong Momentum Stock
2 months

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
2 months

Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.

zacks.com
Why McKesson (MCK) is a Top Value Stock for the Long-Term
3 months

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
3 months

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

zacks.com
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
3 months

In the latest trading session, McKesson (MCK) closed at $599.56, marking a -0.8% move from the previous day.

zacks.com